ENTITY
Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU AU)

38
Analysis
Health CareAustralia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
Refresh
bullishBellevue Gold
22 Mar 2023 05:22

S&P/​​​​​​ASX Index Rebalance Preview: Changes from Now to June

There could be one change for the ASX100 & ASX200 in April and one change for the ASX200 in June. Passive trackers will trade between 4.5-18x ADV...

Logo
454 Views
Share
21 Mar 2023 19:56

Neuren Pharmaceuticals (NEU AU): It’s Not Too Late to Join the Bandwagon; More Stream Is Still Left

Neuren’s North American partner gained FDA approval for its first drug, triggering milestone and royalty payment. Reasonable valuation and upcoming...

Logo
245 Views
Share
21 Mar 2023 18:04

Quiddity Leaderboard-​​​​​​​​​​​ASX Jun 23: OZ Minerals Replacements and Other Changes

Seven Group Holdings (SVW AU) or Chorus Ltd (CNU NZ) could replace OZL in ASX 100 and Bellevue Gold (BGL AU) or Neuren Pharmaceuticals (NEU AU)...

Share
bullishPolyNovo Ltd
15 Mar 2023 07:03

Australia: S&P/​ASX, REMX, GDXJ, MVA, MVW, Other Flows on Friday

Implementation of the S&P/ASX, REMX, GDXJ, MVA and other indices take place at the close on Friday. There will be a lot of passive flow going...

Logo
424 Views
Share
bullishBellevue Gold
06 Mar 2023 04:18

OZ Minerals (OZL AU): Scheme Meeting in April; Potential S&P/ASX Changes

OZL's acquisition by BHP is nearly a done deal. Passive trackers will sell 18.24m shs (A$509m; 9.6x ADV) of OZL on the last trading day. There will...

Logo
429 Views
Share
x